SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-20-015978
Filing Date
2020-06-26
Accepted
2020-06-26 16:31:54
Documents
1
Group Members
VIVO CAPITAL VIII, LLCVIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea123501-sc13ga1vivo_selecta.htm SC 13G/A 127905
  Complete submission text file 0001213900-20-015978.txt   129395
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Subject) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89550 | Film No.: 20994499
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Filed by) CIK: 0001750698 (see all company filings)

IRS No.: 824768569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A